0001011034-11-000027.txt : 20110316
0001011034-11-000027.hdr.sgml : 20110316
20110316161804
ACCESSION NUMBER: 0001011034-11-000027
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20110316
DATE AS OF CHANGE: 20110316
EFFECTIVENESS DATE: 20110316
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARROGENE NANOTECHNOLOGY INC
CENTRAL INDEX KEY: 0001501627
IRS NUMBER: 273439233
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-147950
FILM NUMBER: 11692061
BUSINESS ADDRESS:
STREET 1: 15332 ANTIOCH STREET
STREET 2: 303
CITY: PACIFIC PALISADES
STATE: CA
ZIP: 90272
BUSINESS PHONE: 310-454-9757
MAIL ADDRESS:
STREET 1: 15332 ANTIOCH STREET
STREET 2: 303
CITY: PACIFIC PALISADES
STATE: CA
ZIP: 90272
D/A
1
primary_doc.xml
X0704
D/A
LIVE
0001501627
ARROGENE NANOTECHNOLOGY INC
15332 ANTIOCH STREET
303
PACIFIC PALISADES
CA
CALIFORNIA
90272
310-454-9757
CALIFORNIA
None
None
Corporation
true
2007
Maurizio
Vecchione
15332 Antioch Street
# 303
Pacific Palisades
CA
CALIFORNIA
90272
Executive Officer
Promoter
Julia
Ljubimova
15332 Antioch Street
# 303
Pacific Palisades
CA
CALIFORNIA
90272
Executive Officer
Director
Promoter
Alexander
Ljubimov
15332 Antioch Street
# 303
Pacific Palisades
CA
CALIFORNIA
90272
Executive Officer
Director
Promoter
Robert
Stuckelman
15332 Antioch Street
# 303
Pacific Palisades
CA
CALIFORNIA
90272
Executive Officer
Director
Promoter
Marc
Rosenberg
15332 Antioch Street
# 303
Pacific Palisades
CA
CALIFORNIA
90272
Director
Promoter
Eggehard
Holler
15332 Antioch Street
# 303
Pacific Palisades
CA
CALIFORNIA
90272
Executive Officer
Director
Promoter
Biotechnology
Decline to Disclose
- 06
true
0001011034-10-000197
2010-10-12
false
true
false
0
GVC Capital, LLC
38923
None
None
5350 S. Roslyn Street
# 400
Greenwood Village
CO
COLORADO
80111
CO
COLORADO
MD
MARYLAND
MI
MICHIGAN
NJ
NEW JERSEY
WA
WASHINGTON
false
600000
496550
103450
false
33
60000
true
0
0
false
ARROGENE NANOTECHNOLOGY INC
/s/ Jeff Sperber
Jeff Sperber
CFO
2011-03-15